Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Optiscan Imaging Limited ( (AU:OIL) ) has issued an update.
Optiscan Imaging Limited has unveiled the InSpecta™, a novel microscopic imaging device specifically designed for the veterinary medicine market. This device aims to enhance diagnostics and treatment for companion animals by providing real-time, non-invasive imaging, significantly broadening Optiscan’s market reach. The InSpecta™ will be showcased at the American College of Veterinary Internal Medicine conference and tested at the University of Minnesota College of Veterinary Medicine to support regulatory submissions. The device is expected to fill a crucial gap in veterinary medicine, offering improved diagnostic and treatment capabilities across various animal species, thereby elevating the standard of care in the veterinary field.
More about Optiscan Imaging Limited
Optiscan Imaging Limited is a company operating in the imaging technology industry, specializing in the development of innovative imaging devices. Their primary products focus on enhancing diagnostics and treatment across various sectors, with a recent expansion into the veterinary medicine market.
Average Trading Volume: 155,664
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$96.06M
See more data about OIL stock on TipRanks’ Stock Analysis page.